Vogelzang Mesothelioma

Malignant Pleural Mesothelioma: Further Options
Malignant Pleural Mesothelioma: Further Options To the editor:Reading the guidelines on asbestos-related pleuropulmonary disease,1 I noted that the chapter on treatment options in malignant mesothelioma did not refer to a study of Vogelzang et al2 about pemetrexed ... Read More

Mesothelioma - California Association For Nurse Practitioners
MESOTHELIOMA Not Just a Late Night Commercial . Graciela Hoal, RN, MSN, ACNP-BC . Saturday Session Thoracic Surgery Nurse Practitioner . Greater Los Angeles Veteran Affairs ... Return Doc

MESOTHELIOMA TREATMENT REGIMENS
MESOTHELIOMA TREATMENT REGIMENS Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin with malignant pleural mesothelioma (MS01): a multicentre randomised trial. ... Return Document

Journal Of Clinical Oncology
Vol 21, No 14 July 15, 2003 Mesothelioma: A New Standard of Care? MALIGNANT PLEURAL mesothelioma (MPM) is an un-common malignancy with an estimated incidence of Vogelzang et al6 report the results of a large, randomized trial that compared ... Fetch Content

Malignant Pleural Mesothelioma - CALGB
Malignant Pleural Mesothelioma •2,000 - 3,000 cases per year (USA) •Increasing incidence •Asbestos (50-80%, decreasing) –30 - 40 year latency Vogelzang, J Clin Oncol 21:2636-44, 2003. 6 Radiation Therapy •Need > 40 Gy even for palliation ... Retrieve Content

Lung Cancer And Mesothelioma - CALGB
Lung Cancer and Mesothelioma Robert Kratzke, M.D. John C. Skoglund Professor of Lung Cancer Research Section of Heme/Onc/Transplant Vogelzang, N. J. et al. J Clin Oncol; 21:2636-2644 2003 Fig 1. Kaplan-Meier estimates of overall survival time for all patients (Pts) (A) ... Retrieve Document

Factors Predictive Of Survival Among With Mesothelioma ...
337 Patients With Mesothelioma Treated Between 1984and 1994bythe Cancerand LeukemiaGroupB* (Dr. Vogelzang), University of Chicago Medical Center, Chicago. Supported by CA33601 (Dr. Herndon), CA31946 (Dr. Green), CA04457 (Drs. Chahinian and Suzuki), and CA41287 (Dr. ... Fetch Full Source

Mesothelioma Treatment: Interview With Dr. Vogelzang - YouTube
Http://convoglaw.com/media-center/vid Dr. Vogelzang discusses different treatment options that are currently available to mesothelioma patients. He talks about the two medications that are widely used to treat mesothelioma, Alimta and Platinum, and side effects that patients taking ... View Video

NCCN Malignant Pleural Mesothelioma Guidelines V.1.2012 ...
NCCN Malignant Pleural Mesothelioma Guidelines V.1.2012 – Meeting – 06/17/11 Guideline Page and Request Yes No Abstain Panel Discussion References Vote MPM-3 Internal request: • Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase ... Visit Document

TREATMENT CHALLENGES FOR MALIGNANT MESOTHELIOMA, RODNEY ...
TREATMENT CHALLENGES FOR MALIGNANT MESOTHELIOMA, RODNEY JEROME LANDRENEAU, MD 1 Well, good morning everyone, this is Vogelzang’s work I just presented to you and also some work more recently by von Meerbeck et al who looked at . TREATMENT ... Retrieve Doc

Phase III Study Of Pemetrexed In Combination With Cisplatin ...
Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma By Nicholas J. Vogelzang, James J. Rusthoven, James Symanowski, Claude Denham, E. Kaukel, Pierre Ruffie, Ulrich Gatzemeier, ... Return Document

Mesothelioma Symptoms And Risk Factors With Dr. Vogelzang ...
Http://convoglaw.com/media-center/videos/ Dr. Vogelzang is a medical oncologist with 30 years of experience treating mesothelioma patients. He discusses the ... View Video

New Agents In The Management Of Advanced Mesothelioma
New Agents in the Management of Advanced Mesothelioma Nicholas J. Vogelzang,a Camillo Porta,b,d and Luciano Muttic,d Malignant pleural mesothelioma (MPM) is a seemingly uncommon tumor whose incidence ... Retrieve Document

Malignant Pleural Mesothelioma - Journal Of Association Of ...
Malignant pleural mesothelioma is a rare neoplasm which arises from pleural surface. Most patients present Vogelzang NJ, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant ... Return Document

The Present And Future Of Mesothelioma Treatment: Medical ...
The Present and Future of Mesothelioma Treatment: Medical Oncologist and Researcher Perspective Hedy Lee Kindler, MD Associate Professor of Medicine ... Retrieve Doc

Chemotherapy - Wikipedia, The Free Encyclopedia
Malignant mesothelioma and non-squamous non-small cell lung cancer. Myelosuppression, renal impairment, peripheral neuropathy, ... Read Article

Multimodality Therapy In mesothelioma: Role Of Chemotherapy
Multimodality therapy in mesothelioma: role of chemotherapy Nicholas J. Vogelzang, MD Nevada Cancer Institute, 10,000 West Charleston Boulevard, Suite 260, Las Vegas, NV 89135, USA ... Fetch Content

A Of Chemotherapy Trials Malignant Mesothelioma*
AReviewof Chemotherapy Trials for Malignant Mesothelioma* Christopher W. Ryan, MD;James Herndon, PhD;and NicholasJ. Vogelzang, MD Treatment ofmalignant pleural mesothelioma con¬ ... Get Content Here

MVP And Vinorelbine For Malignant Pleural mesothelioma
With malignant pleural mesothelioma is a major challenge. Mesothelioma is a relatively rare disease, patients 3 Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplartin versus cisplatin ... Read Full Source

Malignant Pleural Mesothelioma
Malignant Pleural Mesothelioma Joseph Friedberg, MD Hedy Lee Kindler, MD Lee Krug, MD Kenneth Rosenzweig, MD ... Retrieve Full Source

Screening, Early Referral And Treatment For Asbestos Related ...
Screening, early referral and treatment for asbestos related cancer Marc de Perrot, MD, MSc, FRCSC Toronto Mesothelioma Research Program University of Toronto ... Read Document